Decrease of peripheral resistance after intraoperative administration of iloprost in patients with and without type 2 diabetes mellitus and with peripheral arterial occlusive disease.
[A case from practice (154). 1. Renovascular hypertension. 2. Type II diabetes mellitus. 3. Grade II/b peripheral arterial occlusive disease].
TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes.
Decrease of peripheral resistance after intraoperative administration of iloprost in patients with and without type 2 diabetes mellitus and with peripheral arterial occlusive disease.
Hirsch K, Säemann M, Walter C, Taher F, Edda S, Mlekusch I, Jäger H, Assadian A, Falkensammer J.
Diab Vasc Dis Res. 2020 May-Jun;17(5):1479164120930589. doi: 10.1177/1479164120930589.
Gender variation in symptomatic peripheral arterial occlusive disease among type-2 diabetic patients.
Al-Zoubi NA, Shatnawi NJ.
SAGE Open Med. 2019 Apr 1;7:2050312119840198. doi: 10.1177/2050312119840198. eCollection 2019.
Neutral effects of SGLT2 inhibitors in acute coronary syndromes, peripheral arterial occlusive disease, or ischemic stroke: a meta-analysis of randomized controlled trials.
Tsai PC, Chuang WJ, Ko AM, Chen JS, Chiu CH, Chen CH, Yeh YH.
Cardiovasc Diabetol. 2023 Mar 13;22(1):57. doi: 10.1186/s12933-023-01789-5.
Ayurveda for a Type 1 Diabetes Patient with Peripheral Arterial Occlusive Disease: A Case Report.
Stapelfeldt E, Berger B, Raak CK, Gupta S.
Complement Med Res. 2024;31(1):94-102. doi: 10.1159/000534992. Epub 2023 Nov 9.
Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products.
Liu JS, Chuang TJ, Chen JH, Lee CH, Hsieh CH, Lin TK, Hsiao FC, Hung YJ.
Endocrine. 2015 Aug;49(3):703-10. doi: 10.1007/s12020-015-0545-6. Epub 2015 Feb 11.
Frequência e fatores relacionados ao índice tornozelo-braquial aberrante em diabéticos.
de Araújo ALGS, Fidelis C, Dos Santos VP, de Araújo JS Filho, Andrade J, Rêgo MAV.
J Vasc Bras. 2016 Jul-Sep;15(3):176-181. doi: 10.1590/1677-5449.009316.
Skin disorders indicating peripheral arterial occlusive disease and chronic venous insufficiency in organ transplant recipients.
Buntinx M, Lavrijsen APM, de Fijter JW, Reinders MEJ, Schepers A, Bouwes Bavinck JN.
J Diabetes Complications. 2020 Sep;34(9):107623. doi: 10.1016/j.jdiacomp.2020.107623. Epub 2020 May 15.
TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes.
Biscetti F, Porreca CF, Bertucci F, Straface G, Santoliquido A, Tondi P, Angelini F, Pitocco D, Santoro L, Gasbarrini A, Landolfi R, Flex A.
Acta Diabetol. 2014 Dec;51(6):1025-32. doi: 10.1007/s00592-014-0664-1. Epub 2014 Oct 17.
Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years.
Kallio M, Forsblom C, Groop PH, Groop L, Lepäntalo M.
Diabetes Care. 2003 Apr;26(4):1241-5. doi: 10.2337/diacare.26.4.1241.
Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
Vedder IR, Levolger S, Dierckx RAJO, Zeebregts CJ, de Vries JPM, Viddeleer AR, Bokkers RPH.
J Vasc Surg. 2020 Dec;72(6):2006-2016.e1. doi: 10.1016/j.jvs.2020.03.050. Epub 2020 Apr 21.
